CRDF vs OKTA · rev $145.0K vs P/E 84, rev $1.57B
Cardiff Oncology Inc (CRDF) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
CRDF currently screens at market cap $238.8M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the CRDF and OKTA stock pages for the full models.
Not investment advice.